Rob Schulman is a partner in Arent Fox’s Intellectual Property practice group where he focuses on all phases of patent law in the areas of biotechnology, pharmaceuticals, and chemical inventions. His major focus is in the area of contested cases at the Patent Office, including interferences, reexaminations (both ex parte and inter partes), as well as inter partes reviews for all types of inventions. Rob also frequently provides advice on validity, non-infringement and claim construction issues in litigation. He has extensive experience in the area of clearance studies for both established and start-up companies.

Rob’s practice includes development of patent portfolios, patent prosecution including application drafting, prosecution of applications and appellate review. Rob has also helped companies establish best practices for patent application writing and claim drafting. Rob has had a special focus in recombinant plant technology, general agricultural technology, vaccines, drug delivery technology, medical devices and polymers.

He regularly speaks at bar association meetings and in front of clients on case law developments in the biotech, chemical and pharmaceutical areas and has been publishing an annual Year in Review relating to such case developments since 2003.

Rob is registered with the US Patent and Trademark Office and is a member of the Court of Appeals for the Federal Circuit and Federal Circuit Inn of Courts. Rob has taught Interference Practice at Georgetown University Law School since 1992.